Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16390 | 28422749 | JCI Insight | Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brain. | 2017 | Details |
| A16391 | 28422172 | Sci Rep | Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population. | 2017 | Details |
| A16392 | 28421320 | Histochem Cell Biol | Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model. | 2017 | Details |
| A16393 | 28420164 | Int J Mol Sci | The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function. | 2017 | Details |
| A16394 | 28420094 | Nutrients | Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. | 2017 | Details |
| A16395 | 28419855 | Clin Gastroenterol Hepatol | A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16396 | 28419755 | J Viral Hepat | A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B. | 2017 | Details |
| A16397 | 28419582 | Magn Reson Med | Free-breathing liver fat quantification using a multiecho 3D stack-of-radial technique. | 2017 | Details |
| A16398 | 28419124 | PLoS One | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. | 2017 | Details |
| A16399 | 28419000 | Exerc Sport Sci Rev | Exercise-Induced Autophagy in Fatty Liver Disease. | 2017 | Details |
| A16400 | 28417561 | CPT Pharmacometrics Syst Pharmacol | Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults. | 2017 | Details |
| A16401 | 28417532 | Diabetes Obes Metab | Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. | 2017 | Details |
| A16402 | 28416740 | Oncotarget | Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
| A16403 | 28415887 | Free Radic Res | Amelioration of late-onset hepatic steatosis in IDH2-deficient mice. | 2017 | Details |
| A16404 | 28415736 | Oncotarget | The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease. | 2017 | Details |
| A16405 | 28414763 | PLoS One | Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. | 2017 | Details |
| A16406 | 28414138 | Biochem Pharmacol | Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. | 2017 | Details |
| A16407 | 28414056 | Eur J Pharmacol | Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice. | 2017 | Details |
| A16408 | 28413661 | Mol Clin Oncol | Non-alcoholic fatty liver disease fibrosis score predicts hematological toxicity of chemotherapy including irinotecan for colorectal cancer. | 2017 | Details |
| A16409 | 28412824 | Arch Iran Med | Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study. | 2017 | Details |
| A16410 | 28411553 | Biomed Pharmacother | Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats. | 2017 | Details |
| A16411 | 28411267 | Diabetes | NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway. | 2017 | Details |
| A16412 | 28411170 | Biochim Biophys Acta Biomembr | The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. | 2017 | Details |
| A16414 | 28406477 | Cell Death Dis | miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice. | 2017 | Details |
| A16415 | 28405325 | United European Gastroenterol J | Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population. | 2016 | Details |
| A16416 | 28404639 | J Lipid Res | Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH. | 2017 | Details |
| A16417 | 28404158 | Lancet Gastroenterol Hepatol | Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. | 2017 | Details |
| A16419 | 28404136 | Lancet Gastroenterol Hepatol | Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. | 2017 | Details |
| A16420 | 28404113 | Lancet Gastroenterol Hepatol | Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. | 2016 | Details |
| A16421 | 28404098 | Lancet Gastroenterol Hepatol | Screening for liver fibrosis in the general population: a call for action. | 2016 | Details |
| A16422 | 28404072 | Lancet Gastroenterol Hepatol | Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. | 2016 | Details |
| A16423 | 28402022 | J Cell Biochem | Steroidogenic Acute Regulatory Protein (StAR) Overexpression Reduces Inflammation and Insulin Resistance in Obese Mice. | 2017 | Details |
| A16424 | 28398960 | AIDS | Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection. | 2017 | Details |
| A16426 | 28397375 | Clin Obes | Elevation of circulating microRNA levels in obese children compared to healthy controls. | 2017 | Details |
| A16427 | 28397039 | J Huazhong Univ Sci Technolog Med Sci | ER stress-mediated cell damage contributes to the release of EDA+ fibronectin from hepatocytes in nonalcoholic fatty liver disease. | 2017 | Details |
| A16428 | 28395890 | Am J Cardiol | Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans. | 2017 | Details |
| A16429 | 28395666 | Lipids Health Dis | Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice. | 2017 | Details |
| A16430 | 28395604 | Mod Rheumatol | Prevalence and risk factors of hyperuricemia: results of the Kailuan cohort study. | 2017 | Details |
| A16431 | 28393828 | Ter Arkh | [Nonalcoholic fatty liver disease: What do we know and what will we have to learn?] | 2017 | Details |
| A16432 | 28393690 | Curr Med Chem | Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products. | 2018 | Details |
| A16433 | 28392404 | Prog Lipid Res | A global perspective on FOXO1 in lipid metabolism and lipid-related diseases. | 2017 | Details |
| A16434 | 28392354 | Diabetes Metab Syndr | Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes. | 2017 | Details |
| A16435 | 28391883 | J Clin Lipidol | Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases. | 2016 | Details |
| A16436 | 28389566 | J Biol Chem | Microbial metabolites in health and disease: Navigating the unknown in search of function. | 2017 | Details |
| A16437 | 28389414 | Cell Signal | Niclosamide: Beyond an antihelminthic drug. | 2017 | Details |
| A16438 | 28388904 | BMC Complement Altern Med | Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study. | 2017 | Details |
| A16440 | 28387617 | J Med Food | Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial. | 2017 | Details |
| A16441 | 28386626 | Internist (Berl) | [Hepatocellular carcinoma]. | 2017 | Details |
| A16442 | 28386616 | Food Funct | Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation. | 2017 | Details |
| A16443 | 28384519 | J Nutr Biochem | Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. | 2017 | Details |
| A16444 | 28383715 | Nutr Rev | Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. | 2017 | Details |
| A16445 | 28382402 | J Gastroenterol | A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. | 2017 | Details |
| A16448 | 28381741 | Intern Med | Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women. | 2017 | Details |
| A16449 | 28381740 | Intern Med | The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
| A16450 | 28381526 | Gut | miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. | 2017 | Details |
| A16451 | 28381382 | Hepatobiliary Pancreat Dis Int | The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population. | 2017 | Details |
| A16452 | 28378853 | Eur J Clin Nutr | Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample. | 2017 | Details |
| A16453 | 28377802 | Ann Med Surg (Lond) | An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. | 2017 | Details |
| A16455 | 28376573 | Aust Fam Physician | The gut microbiome. | 2017 | Details |
| A16456 | 28376114 | PLoS One | High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. | 2017 | Details |
| A16457 | 28376109 | PLoS One | Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis. | 2017 | Details |
| A16458 | 28376101 | PLoS One | Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy. | 2017 | Details |
| A16459 | 28375406 | J Fam Pract | Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP. | 2017 | Details |
| A16460 | 28375109 | Pak J Pharm Sci | Anti hyperlipidemic and hepatoprotective effects of native date fruit variety "Aseel" (Phoenix dactylifera). | 2016 | Details |
| A16461 | 28374992 | Anal Chem | Liquid Extraction Surface Analysis Mass Spectrometry Method for Identifying the Presence and Severity of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16462 | 28373874 | Front Immunol | Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration. | 2017 | Details |
| A16463 | 28373762 | World J Gastroenterol | Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. | 2017 | Details |
| A16464 | 28372259 | Biomed Pharmacother | Medicinal plants and phytochemicals with anti-obesogenic potentials: A review. | 2017 | Details |
| A16465 | 28371475 | J Diabetes Investig | Impact of non-alcoholic fatty pancreas disease on glucose metabolism. | 2017 | Details |
| A16466 | 28371239 | Liver Int | The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. | 2017 | Details |
| A16467 | 28370150 | Aliment Pharmacol Ther | Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease. | 2017 | Details |
| A16470 | 28369989 | J Clin Ultrasound | Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease. | 2017 | Details |
| A16471 | 28369100 | PLoS One | Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease. | 2017 | Details |
| A16472 | 28368295 | Nutrients | Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed Mice. | 2017 | Details |
| A16473 | 28368286 | J Clin Invest | Distinct but complementary contributions of PPAR isotypes to energy homeostasis. | 2017 | Details |
| A16474 | 28367811 | Med Sci (Paris) | [Autophagy in chronic liver diseases: a friend rather than a foe?] | 2017 | Details |
| A16475 | 28367184 | Pak J Med Sci | Identification of Metabolic risk phenotypes predisposing to Non-Alcoholic Fatty Liver Disease in a Pakistani Cohort. | 2020 | Details |
| A16476 | 28366357 | J Pediatr | Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children. | 2017 | Details |
| A16477 | 28365930 | J BUON | Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment. | 2017 | Details |
| A16478 | 28365312 | J Hepatol | Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. | 2017 | Details |
| A16479 | 28364816 | Clin Liver Dis | De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation. | 2017 | Details |
| A16480 | 28364638 | Environ Toxicol Pharmacol | Nrf2 is crucial for the down-regulation of Cyp7a1 induced by arachidonic acid in Hepg2 cells. | 2017 | Details |
| A16481 | 28363784 | Chem Phys Lipids | The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease. | 2017 | Details |
| A16482 | 28362682 | J Clin Gastroenterol | Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A16483 | 28361809 | Ann Ist Super Sanita | Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy. | 2018 | Details |
| A16484 | 28359548 | Gastroenterol Hepatol | Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population. | 2017 | Details |
| A16486 | 28359183 | Expert Opin Drug Metab Toxicol | Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease. | 2017 | Details |
| A16487 | 28359088 | Endocrinology | Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development. | 2017 | Details |
| A16488 | 28358980 | Cochrane Database Syst Rev | Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. | 2017 | Details |
| A16489 | 28358620 | Metab Syndr Relat Disord | Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice. | 2017 | Details |
| A16490 | 28358240 | Radiology | Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16492 | 28357032 | World J Hepatol | Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease. | 2017 | Details |
| A16494 | 28356335 | Pediatrics | Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood. | 2017 | Details |
| A16495 | 28356106 | Lipids Health Dis | Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice. | 2017 | Details |
| A16496 | 28355557 | Cell Rep | Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet. | 2017 | Details |
| A16497 | 28352941 | Diabetologia | EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral? | 2017 | Details |
| A16498 | 28351752 | Exp Cell Res | Deficiency of CKIP-1 aggravates high-fat diet-induced fatty liver in mice. | 2017 | Details |
| A16499 | 28351695 | Chem Biol Interact | Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models. | 2017 | Details |
| A16500 | 28351093 | Horm Metab Res | ANGPTL8 (Betatrophin) is Expressed in Visceral Adipose Tissue and Relates to Human Hepatic Steatosis in Two Independent Clinical Collectives. | 2017 | Details |
| A16501 | 28350839 | PLoS One | Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study. | 2017 | Details |